Affordable Access

deepdyve-link
Publisher Website

MOG-associated encephalitis following SARS-COV-2 infection

Authors
  • Peters, John1
  • Alhasan, Saleh1
  • Vogels, Chantal B.F.2
  • Grubaugh, Nathan D.2
  • Farhadian, Shelli1, 3
  • Longbrake, Erin E.1
  • 1 Department of Neurology, Yale University School of Medicine, 333 Cedar St. New Haven, CT, 06510, USA
  • 2 Department of Epidemiology of Microbial Diseases, Yale School of Public Health, 60 College St, New Haven, CT, 06510, USA
  • 3 Department of Medicine, Section of Infectious Disease, Yale University School of Medicine, 333 Cedar St, New Haven, CT, 06510, USA
Type
Published Article
Journal
Multiple Sclerosis and Related Disorders
Publisher
Elsevier B.V.
Publication Date
Feb 23, 2021
Volume
50
Pages
102857–102857
Identifiers
DOI: 10.1016/j.msard.2021.102857
PMID: 33647592
PMCID: PMC7900751
Source
PubMed Central
Keywords
Disciplines
  • Commentary
License
Unknown

Abstract

A variety of neurologic manifestations of COVID-19 infections have been reported. Here, we present a case of steroid-responsive MOG-antibody associated encephalitis, characterized by cognitive decline, headaches, fever, unilateral FLAIR-hyperintensities, and leptomeningeal enhancement, that occurred in the setting of recent COVID-19 infection.

Report this publication

Statistics

Seen <100 times